Developer docs
API playgroundTry for free, no card

Search company profiles

Medrobotics

Full company profile

uuid0002gvn

Namestring
Medrobotics
Websiteurl
medrobotics.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Medrobotics is a privately held medical robotics company founded in 2005 and headquartered in Raynham, Massachusetts, that develops and commercializes the Flex Robotic System. The company serves hospitals and specialty clinics performing flexible endoscopic surgery, including gastrointestinal, colorectal, and oral procedures, where the Flex platform is positioned to address demand for minimally invasive surgery and improved access to anatomical regions with flexible instruments. Medrobotics is referenced alongside Intuitive Surgical, Medtronic, Stryker, and CMR Surgical as a key player in the broader surgical robotics market, and it holds an estimated 34.9% share of the oral surgery robot segment.

The Flex Robotic System is described as a semi-autonomous platform for flexible endoscopic surgery robots, differentiating Medrobotics through its flexible-scope architecture rather than the rigid laparoscopic approach used by incumbent general surgery robotics systems. Detailed technical specifications, patent counts, and product architecture are not disclosed in the available source material, and no AI/ML capabilities, named models, or data assets are documented. The company operates with 101-250 employees and serves customers in North America, with no documented international commercial presence.

Medrobotics operates a capital equipment business model typical of surgical robotics, selling or placing robotic systems with healthcare providers rather than pursuing a recurring software or consumables-only revenue model. Pricing and distribution channels are not publicly disclosed. Across 14 funding rounds between 2009 and 2018, the company raised approximately $206 million from investors including Western Technology Investment, Hercules Capital, Eagle Ventures, Pittsburgh Life Sciences Greenhouse, and Slater Technology Fund. The last disclosed financing was a $25 million round led by Western Technology Investment in June 2018, and no subsequent funding activity, product launches, partnerships, or acquisitions are documented in the available data.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRaynham, United States
HQ citystring
Raynham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
surgical robotics systems, flexible endoscopic surgery, minimally invasive robotics, robotic assisted surgery, medical robotics platforms
Industry2 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Robotics
Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Medrobotics develops and commercializes the Flex Robotic System, a robotic-assisted surgical platform designed for flexible endoscopic and minimally invasive procedures. The system is targeted at hospitals and specialty clinics performing gastrointestinal, colorectal, transoral, and other natural orifice surgeries that are difficult to access with rigid laparoscopic or conventional endoscopic tools.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medrobotics is a surgical robotics company operating in the broader surgical robotics and robotic endoscopy device markets. The company is mentioned as a key player in the oral surgery robot market, the robotic endoscopy device market, and the U.S. Flexible Endoscopic Surgery Robot Market. However, no specific product names, detailed product descriptions, or product architecture information were available in the provided source material.

Product and service1 record
1Flex Robotic System
CategorySurgical robotics systems
Description

Robotic-assisted surgical platform for flexible endoscopic and minimally invasive procedures, including gastrointestinal, colorectal, transoral, and other natural orifice surgeries. Targeted at hospitals and specialty clinics seeking to access anatomically challenging sites with greater precision than rigid laparoscopic tools allow.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Asensus Surgical develops the Senhance robotic surgical platform for laparoscopic procedures, making it an emerging peer in the same surgical robotics category as Medrobotics. Both are smaller, publicly-traded challengers to Intuitive Surgical.

TypeDirect peer
Description

Medtronic's Hugo robotic-assisted surgery platform places it as a direct peer, mentioned alongside Medrobotics in the surgical robotics market. Both target minimally invasive procedures, though Medtronic competes more broadly across specialties while Medrobotics focuses on flexible endoscopy.

TypeDirect peer
Description

Intuitive Surgical is the dominant player in surgical robotics with the da Vinci platform and is explicitly cited alongside Medrobotics in market reports. Both companies develop robotic-assisted minimally invasive surgical systems, though Intuitive focuses on rigid laparoscopic platforms while Medrobotics specializes in flexible endoscopy.

TypeBroad incumbent
Description

Stryker operates the Mako robotic platform primarily for orthopedic surgery and is mentioned alongside Medrobotics in surgical robotics market reports. As a broad incumbent medical device company, Stryker has substantially more capital, distribution, and installed base than Medrobotics.

TypeEmerging player
Description

Moon Surgical is developing a collaborative surgical robotics platform for laparoscopic procedures. As an emerging player, it represents a newer entrant competing in the same broader surgical robotics category where Medrobotics operates.

TypeEmerging player
Description

Vicarious Surgical is developing a virtual-reality-enabled surgical robotics system. As an emerging player, it shares Medrobotics' positioning as a smaller, technology-focused challenger in surgical robotics with a differentiated platform approach.

TypeDirect peer
Description

CMR Surgical's Versius system is a direct surgical robotics peer, explicitly named in the same market reports as Medrobotics. Both companies develop compact robotic platforms for minimally invasive surgery, competing for hospital capital equipment budgets.

8THINK Surgical
TypeEmerging player
Description

THINK Surgical develops robotic systems for orthopedic surgery, particularly knee procedures. While focused on orthopedics rather than flexible endoscopy, it is comparable as a smaller, specialized surgical robotics platform developer competing against larger incumbents.

TypeEmerging player
Description

Renishaw has developed neurosurgical robotic platforms (Neuromate) and entered the broader surgical robotics market. As a precision engineering company extending into surgical robotics, it is a comparable peer in developing specialized robotic surgical systems for defined clinical niches.

TypeBroad incumbent
Description

Johnson & Johnson is developing the Ottava robotic surgery platform and is cited as a key competitor in the surgical robotics market. As a broad incumbent with massive R&D resources, J&J represents both a competitive threat and a potential strategic acquirer of Medrobotics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds14 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medrobotics

Surgical Roboticsmedrobotics.com

What Medrobotics does

Medrobotics is a privately held medical robotics company founded in 2005 and headquartered in Raynham, Massachusetts, that develops and commercializes the Flex Robotic System. The company serves hospitals and specialty clinics performing flexible endoscopic surgery, including gastrointestinal, colorectal, and oral procedures, where the Flex platform is positioned to address demand for minimally invasive surgery and improved access to anatomical regions with flexible instruments. Medrobotics is referenced alongside Intuitive Surgical, Medtronic, Stryker, and CMR Surgical as a key player in the broader surgical robotics market, and it holds an estimated 34.9% share of the oral surgery robot segment.

The Flex Robotic System is described as a semi-autonomous platform for flexible endoscopic surgery robots, differentiating Medrobotics through its flexible-scope architecture rather than the rigid laparoscopic approach used by incumbent general surgery robotics systems. Detailed technical specifications, patent counts, and product architecture are not disclosed in the available source material, and no AI/ML capabilities, named models, or data assets are documented. The company operates with 101-250 employees and serves customers in North America, with no documented international commercial presence.

Medrobotics operates a capital equipment business model typical of surgical robotics, selling or placing robotic systems with healthcare providers rather than pursuing a recurring software or consumables-only revenue model. Pricing and distribution channels are not publicly disclosed. Across 14 funding rounds between 2009 and 2018, the company raised approximately $206 million from investors including Western Technology Investment, Hercules Capital, Eagle Ventures, Pittsburgh Life Sciences Greenhouse, and Slater Technology Fund. The last disclosed financing was a $25 million round led by Western Technology Investment in June 2018, and no subsequent funding activity, product launches, partnerships, or acquisitions are documented in the available data.

Medrobotics firmographics

Firmographics
Name
Medrobotics
Website
https://medrobotics.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Medrobotics industry classification

Industry
Product category
Surgical Robotics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Surgical robotics systems
  • Flexible endoscopic surgery
  • Minimally invasive robotics
  • Robotic assisted surgery
  • Medical robotics platforms

Where Medrobotics is headquartered

Location

Headquarters

HQ city
Raynham
HQ country
United States
HQ region
North America

Markets served

Medrobotics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Medrobotics product offering

Product offering

Core offering

Medrobotics develops and commercializes the Flex Robotic System, a robotic-assisted surgical platform designed for flexible endoscopic and minimally invasive procedures. The system is targeted at hospitals and specialty clinics performing gastrointestinal, colorectal, transoral, and other natural orifice surgeries that are difficult to access with rigid laparoscopic or conventional endoscopic tools.

Product overview

Medrobotics is a surgical robotics company operating in the broader surgical robotics and robotic endoscopy device markets. The company is mentioned as a key player in the oral surgery robot market, the robotic endoscopy device market, and the U.S. Flexible Endoscopic Surgery Robot Market. However, no specific product names, detailed product descriptions, or product architecture information were available in the provided source material.

Differentiator

Problem solved

Functional benefit

Products and services

  • Flex Robotic System Robotic-assisted surgical platform for flexible endoscopic and minimally invasive procedures, including gastrointestinal, colorectal, transoral, and other natural orifice surgeries. Targeted at hospitals and specialty clinics seeking to access anatomically challenging sites with greater precision than rigid laparoscopic tools allow.

Companies that use Medrobotics

Customer profile

Segments1 record

Ideal customer profiles1 record

Medrobotics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Medrobotics partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Medrobotics competitors and assessment

Company assessment

Emerging players

  • Asensus Surgical: Asensus Surgical develops the Senhance robotic surgical platform for laparoscopic procedures, making it an emerging peer in the same surgical robotics category as Medrobotics. Both are smaller, publicly-traded challengers to Intuitive Surgical.
  • Moon Surgical: Moon Surgical is developing a collaborative surgical robotics platform for laparoscopic procedures. As an emerging player, it represents a newer entrant competing in the same broader surgical robotics category where Medrobotics operates.
  • Vicarious Surgical: Vicarious Surgical is developing a virtual-reality-enabled surgical robotics system. As an emerging player, it shares Medrobotics' positioning as a smaller, technology-focused challenger in surgical robotics with a differentiated platform approach.
  • THINK Surgical: THINK Surgical develops robotic systems for orthopedic surgery, particularly knee procedures. While focused on orthopedics rather than flexible endoscopy, it is comparable as a smaller, specialized surgical robotics platform developer competing against larger incumbents.
  • Renishaw: Renishaw has developed neurosurgical robotic platforms (Neuromate) and entered the broader surgical robotics market. As a precision engineering company extending into surgical robotics, it is a comparable peer in developing specialized robotic surgical systems for defined clinical niches.

Direct peers

  • Medtronic: Medtronic's Hugo robotic-assisted surgery platform places it as a direct peer, mentioned alongside Medrobotics in the surgical robotics market. Both target minimally invasive procedures, though Medtronic competes more broadly across specialties while Medrobotics focuses on flexible endoscopy.
  • Intuitive Surgical: Intuitive Surgical is the dominant player in surgical robotics with the da Vinci platform and is explicitly cited alongside Medrobotics in market reports. Both companies develop robotic-assisted minimally invasive surgical systems, though Intuitive focuses on rigid laparoscopic platforms while Medrobotics specializes in flexible endoscopy.
  • CMR Surgical: CMR Surgical's Versius system is a direct surgical robotics peer, explicitly named in the same market reports as Medrobotics. Both companies develop compact robotic platforms for minimally invasive surgery, competing for hospital capital equipment budgets.

Broad incumbents

  • Stryker: Stryker operates the Mako robotic platform primarily for orthopedic surgery and is mentioned alongside Medrobotics in surgical robotics market reports. As a broad incumbent medical device company, Stryker has substantially more capital, distribution, and installed base than Medrobotics.
  • Johnson & Johnson (Johnson & Johnson MedTech): Johnson & Johnson is developing the Ottava robotic surgery platform and is cited as a key competitor in the surgical robotics market. As a broad incumbent with massive R&D resources, J&J represents both a competitive threat and a potential strategic acquirer of Medrobotics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Medrobotics social profiles

Digital presence

Medrobotics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medrobotics leadership team

Management profile

Number of profiles

Profiles7 records

Medrobotics funding detail

Funding detail

Funding overview

Funding rounds14 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medrobotics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medrobotics

What does Medrobotics do?

Medrobotics develops and commercializes the Flex Robotic System, a robotic-assisted surgical platform designed for flexible endoscopic and minimally invasive procedures. The system is targeted at hospitals and specialty clinics performing gastrointestinal, colorectal, transoral, and other natural orifice surgeries that are difficult to access with rigid laparoscopic or conventional endoscopic tools.

When was Medrobotics founded?

Medrobotics was founded in 2005. It employs 11 to 50 people.

Where is Medrobotics based?

Medrobotics is headquartered in Raynham, United States, in the North America region.

Who are Medrobotics's main competitors?

Emerging players on record are Asensus Surgical, Moon Surgical, Vicarious Surgical, THINK Surgical and Renishaw. Direct peers are Medtronic, Intuitive Surgical and CMR Surgical. Broad incumbents are Stryker and Johnson & Johnson (Johnson & Johnson MedTech).

Does Medrobotics have an API?

No public API is recorded for Medrobotics.

What industry is Medrobotics in?

Medrobotics's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
RobohubSnake robots slither into our hearts, literallyGeneral Electric's Aviation unit completed the acquisition of OC Robotics, a leader in serpent arm design, to enable jet engine maintenance repairs while engines remain attached to wings. The technology offers significant cost and time savings for airlines and has broader applications in inspections, nuclear decommissioning, and industrial safety. Meanwhile, Medrobotics received FDA clearance for its Flex Robotic System, marking the first steerable snake robot approved for colorectal procedures in the U.S.Data Insights MarketUnlocking the Future of Oral Surgery Robot: Growth and Trends 2026-2034A market research report projects the global oral surgery robot market will grow from approximately $250 million in 2025 at a CAGR of 20.7%, reaching several billion USD by 2033, driven by technological advancements, rising prevalence of oral diseases, and increasing adoption of minimally invasive procedures. Key players including Intuitive Surgical (34.9% market share), Medrobotics, Penn Medicine, and Beijing Kemai Qiyuan Technology are investing heavily in R&D to expand their product portfolios amid challenges such as high initial investment costs and a shortage of skilled surgeons. North America currently dominates the market (45% share), though Asia-Pacific is expected to witness significant growth due to expanding healthcare infrastructure and rising disposable incomes.Mobility ForesightsNorth America Robotic Endoscopy Device Market Size and Forecasts 2031The North America robotic endoscopy device market is projected to grow from USD 1.98 billion in 2025 to USD 4.23 billion by 2031, at a compound annual growth rate of 13.6%. Key drivers include rising demand for minimally invasive procedures, increasing gastrointestinal and pulmonary disease prevalence, and technological advancements in AI-guided navigation, 3D imaging, and capsule robotics. Major players such as Intuitive Surgical, Medtronic, Johnson & Johnson's Auris Health, Olympus Corporation, and Medrobotics are advancing robotic bronchoscopy, colonoscopy, and capsule endoscopy platforms across North American hospitals and specialty clinics.YahooU.S. Flexible Endoscopic Surgery Robot Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034The U.S. Flexible Endoscopic Surgery Robot Market was valued at USD 326.4 million in 2024 and is projected to grow at a compound annual growth rate of 14.7% to reach USD 1.3 billion by 2034. The expansion is driven by rising preference for minimally invasive procedures, advancements in robotic precision and AI integration, and increasing prevalence of gastrointestinal and colorectal disorders alongside an aging population. Key players in the market include Asensus Surgical, CMR Surgical, Endo Tools Therapeutics, GI View, Intuitive Surgical, Johnson & Johnson, Medrobotics, and Medtronic, which are focusing on strategic partnerships and technological innovation.Patient Care at NYU Langone HealthA New Era in Advanced EndoscopyNYU Langone Health gastroenterologists and surgeons are integrating robotics and artificial intelligence into advanced endoscopy to treat gastrointestinal cancers and premalignant lesions. The team utilizes the Medrobotics Flex Robotic System for minimally invasive procedures, such as transanal total mesorectal excisions, while employing AI tools to enhance polyp detection during colonoscopies. These innovations aim to reduce unnecessary surgeries, improve patient recovery times, and expand minimally invasive treatment options.Business & FinancialInnovations In Medical Robotic System Market: What To Expect By 2031 Irobot Corporation, Medrobotics CorporationThe medical robotic system market is projected to grow from USD 21.3 billion in 2024 to USD 63.1 billion by 2031, a CAGR of 16.8%. The report highlights key players including iRobot Corporation and Medrobotics Corporation, and covers segmentation by product type, end user, and region.SciencedirectNew Endoluminal platforms and advancements in technology: Should Gastroenterologists or Surgeons pave the way?The article argues that surgeons should lead endoluminal operations over gastroenterologists, citing their training in tissue manipulation, anatomical knowledge, complication management and shorter procedure times. It reviews robotic platforms such as the DaVinci SP, Medrobotics Flex-Robotic, Endo-Master, ELS and STRAS, describing them as bridges toward true robotic surgical systems.PR NewswireAll Assets from Medrobotics' 40,000-Square-Foot Massachusetts Plant Available in Turnkey SaleMedrobotics, a maker of FDA-approved robotic surgical platforms used by nearly 30 hospitals globally, is liquidating all assets from its 40,000-square-foot manufacturing plant in Raynham, Massachusetts through Tiger Group and Liquidity Services. The turnkey sale includes $12 million in hard assets, 23 complete Flex and Flex360 robotics systems, and 22 terabytes of technical specifications, customer lists and other intellectual property. The 700 lots will be sold through a timed online auction closing on June 11, 2024.PR NewswireEndobotics, LLC Wins Patent and Trade Secrets Infringement Lawsuits Against Medrobotics CorporationEndobotics, LLC secured two favorable judgments from U.S. District Courts in Delaware and Massachusetts in lawsuits alleging patent infringement, trade secrets violations, breach of contract, and unfair competition against Medrobotics Corporation. The courts awarded Endobotics a total of $191,648,614 in damages. The company, which holds more than 23 patents in hand-held and robotic-assisted instruments for minimally invasive surgery, filed the initial lawsuit in early 2019 and plans to continue pursuing intellectual property enforcement.VideogieRobotic-assisted surgical endoscopy: a new era for endoluminal therapiesA video vignette demonstrates robotic-assisted surgical endoscopy using Medrobotics' Flex robotic system, modified to maintain insufflation for gastrointestinal procedures, in ex-vivo animal models. The 18 mm by 28 mm device reaches lesions up to 25 cm from the anal verge and supports Zenker diverticulum treatment, ESD, full-thickness resection and suturing. Authors call further clinical studies warranted.